Navidea Biopharmaceuticals Announces Positive Results of First Interim Analysis of Ongoing Phase 2B Study in Rheumatoid Arthritis
Stock Information for Navidea Biopharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.